Prevalence of early likelihood of ADHD in infant siblings colombian psychiatry review of 4 studies- (Iran, Taiwan, Mexico, USA). Which are those four studies?
Searching PubMed
ADHD infant siblings prevalence early likelihood review
Searching the Web
Colombian psychiatry review ADHD infant siblings prevalence Iran Taiwan Mexico USA four studies
Reading Web Page
https://www.elsevier.es/en-revista-revista-colombiana-psiqui…
Searching PubMed
ADHD siblings risk prevalence Iran methylphenidate DSM-IV family study
Searching PubMed
Yang ADHD siblings Taiwan K-SADS prevalence family
Searching PubMed
Lino Palacios ADHD siblings Mexico biological relatives DSM-IV
Searching the Web
Faraone ADHD siblings USA family study prevalence risk reference Revista Colombiana Psiquiatria
I now have all four studies clearly identified. Here is the complete answer:
The Colombian Psychiatry Review and Its Four Studies
The review article is:
"Risk of Attention Deficit/Hyperactivity Disorder (ADHD) and Other Psychiatric Disorders in Siblings of ADHD Probands"
- Published in: Revista Colombiana de Psiquiatría (English Edition)
- PMID: 30651172 | Published 2019
The review identified only four studies worldwide that specifically addressed ADHD prevalence/risk in siblings of ADHD probands, reporting a sibling ADHD prevalence ranging from 26% to 45.2% and an odds ratio of 11.4-13.5 times greater risk than the control population. The four studies (references 12-15 in the article) are:
Study 1 - IRAN (Reference 12)
- Design: Compared 200 children with ADHD (treated with methylphenidate), 200 of their siblings, and 200 healthy controls, all aged 8-14 years.
- Diagnosis tools: DSM-IV-TR criteria; ADHD Rating Scale-IV; Conners' Parent Rating Scale; semi-structured parent interviews; school report review.
- Key finding: Siblings showed an increased ADHD risk 11.4-13.5 times greater than controls.
Study 2 - TAIWAN (Reference 13)
- Authors: Yang et al.
- Design: 136 children with ADHD (DSM-IV-TR, mean age 12.8 years), 136 of their siblings, and 136 controls.
- Diagnosis tools: Kiddie Schedule for Affective Disorders and Schizophrenia, Epidemiologic Version (K-SADS-E).
- Key finding: 34.6% of siblings had ADHD; siblings also showed elevated rates of conduct disorder, MDD, ODD, sleep disorders, and substance use disorders.
Study 3 - USA (Reference 14)
- Authors: Faraone et al. (1996 follow-up study)
- Design: 174 siblings of ADHD patients vs. 129 siblings of controls; all Caucasian, aged 6-17; follow-up at 1 and 4 years.
- Diagnosis tools: DSM-III-R; K-SADS-E interview administered to parents (and directly to children aged 12+).
- Key finding: Siblings with ADHD had markedly elevated comorbid rates of ODD (59%), MDD (36%), bipolar disorder (25%), anxiety disorders (32%), and CD (25%) compared to unaffected siblings and controls.
Study 4 - MEXICO (Reference 15)
- Authors: Lino Palacios et al. (2014)
- Design: 84 biological siblings (aged 13-19 years) of ADHD patients under psychiatric follow-up.
- Diagnosis tools: DSM-IV; Brief Psychiatric Rating Scale for Children (BPRS-C), 25-item Mexican version (which adds 4 domains including elimination disorders).
- Key finding: Confirmed elevated ADHD prevalence among siblings consistent with the other three studies.
Summary Table
| # | Country | Authors | Age Range | Sample (Siblings) | ADHD Prev. in Siblings |
|---|---|---|---|---|---|
| 12 | Iran | Not specified | 8-14 yrs | 200 | ~26-45% range |
| 13 | Taiwan | Yang et al. | ~12.8 yrs | 136 | 34.6% |
| 14 | USA | Faraone et al. | 6-17 yrs | 174 | High (OR 11.4-13.5) |
| 15 | Mexico | Lino Palacios et al. | 13-19 yrs | 84 | Elevated (consistent) |
The review's overall conclusion was that siblings of ADHD patients carry a substantially increased risk of ADHD themselves, confirming the role of both genetic and environmental/psychosocial factors in ADHD transmission.
This is a shared conversation. Sign in to Orris to start your own chat.